Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain

Journal of Enzyme Inhibition and Medicinal Chemistry
Hak Kyun YangAe Nim Pae

Abstract

The treatment of neuropathic pain is one of the urgent unmet medical needs and T-type calcium channels are promising therapeutic targets for neuropathic pain. Several potent T-type channel inhibitors showed promising in vivo efficacy in neuropathic pain animal models and are being investigated in clinical trials. Herein we report development of novel pyrrolidine-based T-type calcium channel inhibitors by pharmacophore mapping and structural hybridisation followed by evaluation of their Cav3.1 and Cav3.2 channel inhibitory activities. Among potent inhibitors against both Cav3.1 and Cav3.2 channels, a promising compound 20n based on in vitro ADME properties displayed satisfactory plasma and brain exposure in rats according to in vivo pharmacokinetic studies. We further demonstrated that 20n effectively improved the symptoms of neuropathic pain in both SNL and STZ neuropathic pain animal models, suggesting modulation of T-type calcium channels can be a promising therapeutic strategy for the treatment of neuropathic pain.

References

Jul 15, 1970·European Journal of Pharmacology·P A JanssenW K Schaper
Jan 1, 1980·Annual Review of Pharmacology and Toxicology·W J Dixon
Jul 1, 1994·Journal of Neuroscience Methods·S R ChaplanT L Yaksh
Sep 17, 1998·Circulation·R SoRelle
Feb 29, 2000·The Journal of Biological Chemistry·A MonteilJ Nargeot
Dec 31, 2002·Physiological Reviews·Edward Perez-Reyes
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·K O Aley, J D Levine
Mar 19, 2004·Bioorganic & Medicinal Chemistry·Munikumar Reddy DoddareddyAe Nim Pae
Oct 7, 2004·Biochemical and Biophysical Research Communications·Taehyun KimHyewhon Rhim
Mar 24, 2006·Nature·Michael C Sanguinetti, Martin Tristani-Firouzi
Aug 26, 2006·Nature Clinical Practice. Neurology·Nanna B Finnerup, Troels S Jensen
Dec 16, 2006·CNS & Neurological Disorders Drug Targets·Slobodan M Todorovic, Vesna Jevtovic-Todorovic
Feb 19, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Min-Chul ShinNorio Akaike
Dec 2, 2008·Trends in Pharmacological Sciences·Mircea C Iftinca, Gerald W Zamponi
Aug 5, 2009·Diabetes·Janelle R LathamVesna Jevtovic-Todorovic
Oct 7, 2009·The American Journal of Medicine·Alec B O'Connor, Robert H Dworkin
Jul 24, 2010·Lancet Neurology·Ralf BaronGunnar Wasner
Feb 22, 2012·Science Translational Medicine·Elizabeth TringhamTerrance P Snutch
Jan 3, 2014·Physiological Reviews·Emmanuel BourinetGerald W Zamponi
Jan 13, 2015·Lancet Neurology·Nanna B FinnerupMark Wallace
Feb 2, 2016·Free Radical Biology & Medicine·Lorenzo Di Cesare MannelliPaola Failli
Feb 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Soonwook ChoiRodolfo R Llinás
May 3, 2016·Experimental Neurology·Alessandra PaciniLorenzo Di Cesare Mannelli
Feb 17, 2017·Nature Reviews. Disease Primers·Luana CollocaSrinivasa N Raja

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotide
column chromatography
NMR

Software Mentioned

pCLAMP8
CATALYST
FDSS6000
HipHop

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.